Lung Research future directions for LIWA. Yuben Moodley

Size: px
Start display at page:

Download "Lung Research future directions for LIWA. Yuben Moodley"

Transcription

1 Lung Research future directions for LIWA Yuben Moodley

2 INTRODUCTION If you think about the following diseases: COPD, emphysema, asthma, cystic fibrosis, lung cancer, bronchiectasis, asbestosis, lung fibrosis, sarcoidosis You will appreciate that 1 in 4 Australians have lung disease

3 INTRODUCTION COPD-emphysema and bronchitis by 2020 will be the 3 rd commonest cause of global morbidity and mortality. If you add certain infections such as TB then lung disease is a major global crisis

4 INTRODUCTION The surface area of the lung is 70m l/day of air Oxygen consumption 250 to 5500 ml/min Pulmonary blood flow 4 to 40l/min

5 LUNG DISEASE THE SILENT SUFFERERS Short of breath - you withdraw These people need advocates

6 The Lung Institute of WA (LIWA) Our aims Support high quality research into the treatment and management of lung diseases. Support research into associated conditions. Improve the well-being of patients. Support the careers of young scientists. Provide a strong educational and scientific resource for the community. Be an advocacy group for better lung health.

7 THE ALGORITHM OF DISEASE Genetics, epigenetics Injury Inflammation Normal repair and regeneration Impaired/pathological repair Fibrosis cancer Chronic lung disease

8 THE ALGORITHM OF DISEASE GENETICS Prof Philip Thompson Dr Svetlana Baltic Genetics, epigenetics Injury/Infection PLEURAL Prof Gary Lee Asthma, COPD Inflammation CLINICAL TRIALS UNIT Prof Philip Thompson CYSTIC FIBROSIS Dr Siobhan Mulroonan Normal repair and regeneration Impaired/pathological repair PHYSIOTHERAPY A/Prof Sue Jenkins ADVANCED LUNG Prof Eli Gabbay STEM CELL A/Prof Yuben Moodley Fibrosis Chronic lung disease cancer TISSUE REPAIR GROUP Prof Steven Mustsaers A/Prof Cecilia Prele

9 FUNDING STRATEGY Cutting edge research Collaboration Community engagement

10 COLLABORATION THE THREE PICTURE RATING WESTERN AUSTRALIA AUSTRALIA INTERNATIONAL

11 Molecular Genetics and Inflammation Unit GENETICS Prof Philip Thompson Dr Svetlana Baltic Asthma, COPD Genetics, epigenetics Inflammation Injury/Infection Normal repair and regeneration Impaired/pathological repair Fibrosis cancer Chronic lung disease

12 Molecular Genetics and Inflammation Unit PERSONALIZED TREATMENT FOR ASTHMA Why? Current treatments are not effective for everyone How? use of LIWA cohort of over 1200 asthmatics with the largest cohort of severe asthmatics Genotyping of ADRβ2 polymorphisms Investigating pharmacogenetic effect of ADRβ2 polymorphisms on receptor expression and activation in the presence or absence of ADRβ2 agonists (eg. Ventolin)

13 Molecular Genetics and Inflammation Unit Developing New Treatments for Lung Diseases Identifying new molecular targets Generating more effective treatments Halting disease progression Inhibition of the cycle of chronic inflammation Big cohort of patients with inflammatory airway diseases ASTHMA COPD BRONCHIECTASIS CYSTIC FIBROSIS

14 Molecular Genetics and Inflammation Unit 1) Genotyping and association studies, Australian Genetic Consortium, National International Collaborations Publications (Nature Genetics, Lancet, etc) Pharmaceutical Companies 2) Explore different strategies of modifying gene expression CRC for Asthma and Airways, National Multicentre Collaboration Patient, publications 3) Research in the field of pharmacogenetics, University of Adelaide, Brisbane 4) Discover molecular mechanisms of gene regulation, splicing and expression Local and National, potential for International Collaborations

15 TISSUE REPAIR GROUP Genetics, epigenetics Injury/Infection Asthma, COPD Inflammation Normal repair and regeneration Impaired/pathological repair Fibrosis Chronic lung disease cancer TISSUE REPAIR GROUP Prof Steven Mustsaers A/Prof Cecilia Prele

16 TISSUE REPAIR GROUP IDIOPATHIC PULMONARY FIBROSIS (IPF)

17 TISSUE REPAIR GROUP STAT3 regulation of cell responses in IPF GP130 STAT 3 MAPK INCREASED LUNG FIBROSIS PROTECTIVE AGAINST LUNG FIBROSIS

18 TISSUE REPAIR GROUP LUNG FIBROSIS IL-6/gp130/STAT signalling in the pathogenesis of pulmonary fibrosis. The role of the epithelium in regulating B cell activity (G Laurent, G Hoyne, M Ernst, R O Donoghue) SOCS-mediated regulation of STAT signalling in IPF BARD-1 in the pathogenesis of lung fibrosis (G Laurent and I Irminger-Finger) Role of Fibulin-1 in IPF (J Burgess and J Black) MESOTHELIOMA Collagen/TGF-β signalling in mesothelioma (G Laurent, R McAnulty) MiRNAs in mesothelioma: diagnostic and biological role (W Musk G Reid, M Kirschner, J Creaney, B Robinson, G Lee) Hedgehog signalling pathway in mesothelial repair and the pathogenesis of mesothelioma: mutations, mechanisms, therapeutics (N Watkins, A Nowak) BARD-1 in the pathogenesis of mesothelioma (I Irminger-Finger) Plasticity of mesothelial cells (R Dilley)

19 PLEURAL GROUP Genetics, epigenetics Injury/Infection PLEURAL Prof Gary Lee Asthma, COPD Inflammation Normal repair and regeneration Impaired/pathological repair Fibrosis cancer Chronic lung disease

20 PLEURAL GROUP CLINICAL PLEURAL SERVICE LABORATORY RESEARCH PATIENT BASED RESEARCH

21 PLEURAL GROUP

22 PLEURAL GROUP MALIGNANT PLEURAL EFFUSION New Molecular Targets MPM Gene Profiling Novel Biomarkers Novel Concepts for Fluid Control WA MPE study Phase III: IPC vs Talc IPC complication studies

23 PLEURAL GROUP PLEURAL INFECTION In vitro Animal Model Clinical Trials Bacteria on mesothelial cells Murine model Open label Follow-up MIST-2

24 PLEURAL GROUP WA NETWORK ASIA-PACIFIC NETWORK

25 STEM CELL Genetics, epigenetics Injury/Infection Asthma, COPD Inflammation Normal repair and regeneration Impaired/pathological repair Fibrosis cancer STEM CELL A/Prof Yuben Moodley Chronic lung disease

26 STEM CELL

27 STEM CELL GROUP-CYSTIC FIBROSIS CFTR gene mutations CFTR dysfunction Altered ion transport Loss of ASL, thick viscous secretions and impaired mucociliary clearance Chronic bacterial infection Chronic inflammation and fibrosis Bronchiectasis, pulmonary hypertension and cor pulmonale

28 STEM CELL GROUP normal Cystic fibrosis Figure 1. Pathogenesis of CF. In the normal airway (A), Sodium is absorbed by the cell and Chloride (Cl) is secreted by the CFTR. In CF the CFTR is defective which results in no secretion of Cl into the airway. This results in increased absorption of Na, paracellular absorption of Cl and water resulting in a reduction of the air surface liquid (ASL).

29 STEM CELL GROUP WA NETWORK Cell and tissue therapy centre of WA (Dr Marian Sturm) Human studies in COPD CCTRM-Geoff Laurent CYSTIC FIBROSIS-Steve Stick and Anthony Kicic LARGE ANIMAL MODELS VENTILATED PIG AND STEM CELLS-Manitoba (Dr Ruth Mcgrath) REPROGRAMINGpluripotent cells to lung epithelium-barcelona- Dr Michael Edel- CYSTIC FIBROSIS- North Carolina-Dr Robert Tarran

30 CLINICAL TRIALS/CLINICAL SCIENCES GROUP Genetics, epigenetics Injury/Infection Asthma, COPD Inflammation CLINICAL TRIALS UNIT Prof Philip Thompson CYSTIC FIBROSIS Dr Siobhan Mulroonan Normal repair and regeneration Impaired/pathological repair PHYSIOTHERAPY A/Prof Sue Jenkins ADVANCED LUNG Prof Eli Gabbay Fibrosis Chronic lung disease cancer

31 CLINICAL TRIALS/CLINICAL SCIENCES GROUP Clinical trials allow recruitment of patients for research Education of patients Brings cutting edge technology and the latest therapies to patients Income Trials in asthma and COPD

32 LIWA-COMMUNITY ENGAGEMENT Medical Research Seminar Series Delirium 24-Hour Cycle Race The Search for Perth s Best Set of Lungs HBF Run for a Reason Delirium 24-hour cycle race Flu Vaccination Clinic Cook for a Cure Cook for a Cure Chevron City to Surf Corporate lung testing Melbourne Cup Luncheon World COPD Day lung testing Members functions Melbourne Cup Luncheon The Search for Perth s Best Set of Lungs

33 LIWA-COMMUNITY ENGAGEMENT LIWA Grants The Alan King Westcare Grant The LIWA Glenn Brown Memorial Grant The LIWA Sarcoidosis and Other Granulomatous Lung Diseases Project Grant Scholarships PhD Honours Summer Vacation Cadetships Funds raised for the LIWA Glenn Brown Memorial Grant Awards Junior and Senior travel awards

34 OPPORTUNITES FOR COLLABORATION Personalized medicine Biomarkers for diagnosis and preventative medicine Reversing tissue remodeling (scar) Replace scar tissue with healthy tissue Curing cancer

35 Large animal models OPPORTUNITES FOR COLLABORATION Human organs for experimentation-long term preservation Signal transduction Genetic and epigenetic regulation of disease Gene and cell delivery to the human lung Novel imaging of disease processes

LIWA Treatment Gave the Gift of Comfort

LIWA Treatment Gave the Gift of Comfort A breath of Newsletter of the Lung Institute of Western Australia (Inc) 2015 LIWA Treatment Gave the Gift of Comfort This year will be Chris s first Christmas without her husband, Rod who earlier this

More information

Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program

Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program Introduction: Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and

More information

Griffith University - Case for Support. Mesothelioma Research Program

Griffith University - Case for Support. Mesothelioma Research Program Griffith University - Case for Support Mesothelioma Research Program Professor Lyn Griffiths Director, Dean, Research and Director, Genomics Research Centre (GHI) Established in 2007. Integrated health

More information

The Global Alliance against Chronic Respiratory Diseases

The Global Alliance against Chronic Respiratory Diseases The Global Alliance against Chronic Respiratory Diseases Pulmonary hypertension Dr Marc Humbert What is the burden of pulmonary hypertension? The true burden of pulmonary hypertension is currently unknown

More information

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing These Are Hopeful Times for Lung Cancer Survivors When people first learn they have cancer, they are often afraid. But

More information

Pulmonary interstitium. Interstitial Lung Disease. Interstitial lung disease. Interstitial lung disease. Causes.

Pulmonary interstitium. Interstitial Lung Disease. Interstitial lung disease. Interstitial lung disease. Causes. Pulmonary interstitium Interstitial Lung Disease Alveolar lining cells (types 1 and 2) Thin elastin-rich connective component containing capillary blood vessels Interstitial lung disease Increase in interstitial

More information

Roche Position on Human Stem Cells

Roche Position on Human Stem Cells Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with

More information

In this issue. Director s report 2. L I F E Update 4 A novel therapeutic 5 approach to treat malignant mesothelioma

In this issue. Director s report 2. L I F E Update 4 A novel therapeutic 5 approach to treat malignant mesothelioma A breath of Newsletter of the Lung Institute of Western Australia (Inc) New Grants Guarantee Lung Research Seven lung research projects have been guaranteed this quarter with confirmation of funding from

More information

University of Kansas. Respiratory Care Education

University of Kansas. Respiratory Care Education University of Kansas Respiratory Care Education What is Respiratory Care? Respiratory Care is the health profession that specializes in the promotion of optimum cardiopulmonary function and health Respiratory

More information

Influenza (Flu) Influenza is a viral infection that may affect both the upper and lower respiratory tracts. There are three types of flu virus:

Influenza (Flu) Influenza is a viral infection that may affect both the upper and lower respiratory tracts. There are three types of flu virus: Respiratory Disorders Bio 375 Pathophysiology General Manifestations of Respiratory Disease Sneezing is a reflex response to irritation in the upper respiratory tract and is associated with inflammation

More information

1 ALPHA-1. Am I an Alpha-1 Carrier? FOUNDATION FOUNDATION. Learn how being an Alpha-1 carrier can affect you and your family

1 ALPHA-1. Am I an Alpha-1 Carrier? FOUNDATION FOUNDATION. Learn how being an Alpha-1 carrier can affect you and your family Am I an Alpha-1 Carrier? 1 ALPHA-1 FOUNDATION The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of people affected by Alpha-1 worldwide.

More information

Respiratory Care. A Life and Breath Career for You!

Respiratory Care. A Life and Breath Career for You! Respiratory Care A Life and Breath Career for You! Respiratory Care Makes a Difference At 9:32 am, Lori Moreno brought a newborn baby struggling to breathe back to life What have you accomplished today?

More information

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH FUNDING OPPORTUNITY DESCRIPTION 2016 REQUEST FOR APPLICATION (RFA) Lung Cancer Foundation of America (LCFA) and the International

More information

Chronic obstructive pulmonary disease (COPD)

Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is the name for a group of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways

More information

MALIGNANT PLEURAL FLUIDS AID MESOTHELIOMA CELL GROWTH AND PROPAGATION

MALIGNANT PLEURAL FLUIDS AID MESOTHELIOMA CELL GROWTH AND PROPAGATION MALIGNANT PLEURAL FLUIDS AID MESOTHELIOMA CELL GROWTH AND PROPAGATION HUI MIN CHEAH PhD Candidate School of Medicine and Pharmacology University of Western Australia Lung Institute of Western Australia

More information

April 2015 CALGARY ZONE CLINICAL REFERENCE PULMONARY CENTRAL ACCESS & TRIAGE

April 2015 CALGARY ZONE CLINICAL REFERENCE PULMONARY CENTRAL ACCESS & TRIAGE April 2015 CALGARY ZONE CLINICAL REFERENCE CENTRAL ACCESS & TRIAGE Introduction Pulmonary consulting services are organized through the Calgary Zone Pulmonary Central Access and Triage (PCAT). Working

More information

Pulmonary Disorders. Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disorders. Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD) RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Pulmonary Disorders Chronic Obstructive Pulmonary Disease (COPD) Characterized by decreased expiratory airflow Reduction in expiratory

More information

1 ALPHA-1. What is Alpha-1? A family history... of lung disease? of liver disease? FOUNDATION

1 ALPHA-1. What is Alpha-1? A family history... of lung disease? of liver disease? FOUNDATION What is Alpha-1? A family history... of lung disease? of liver disease? What you need to know about Alpha-1 Antitrypsin Deficiency 1 ALPHA-1 FOUNDATION What is Alpha-1? Alpha-1 Antitrypsin Deficiency (Alpha-1)

More information

Stem Cell Quick Guide: Stem Cell Basics

Stem Cell Quick Guide: Stem Cell Basics Stem Cell Quick Guide: Stem Cell Basics What is a Stem Cell? Stem cells are the starting point from which the rest of the body grows. The adult human body is made up of hundreds of millions of different

More information

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1 1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY

More information

Department of Surgery

Department of Surgery What is emphysema? 2004 Regents of the University of Michigan Emphysema is a chronic disease of the lungs characterized by thinning and overexpansion of the lung-like blisters (bullae) in the lung tissue.

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

Asbestos and your lungs

Asbestos and your lungs This information describes what asbestos is and the lung conditions that are caused by exposure to it. It also includes information about what to do if you have been exposed to asbestos, and the benefits

More information

Pharmacology of the Respiratory Tract: COPD and Steroids

Pharmacology of the Respiratory Tract: COPD and Steroids Pharmacology of the Respiratory Tract: COPD and Steroids Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart

More information

Information for patients and the public and patient information about DNA / Biobanking across Europe

Information for patients and the public and patient information about DNA / Biobanking across Europe Information for patients and the public and patient information about DNA / Biobanking across Europe BIOBANKING / DNA BANKING SUMMARY: A biobank is a store of human biological material, used for the purposes

More information

Asbestos Diseases. What Is Asbestos?

Asbestos Diseases. What Is Asbestos? 1 Asbestos Diseases What Is Asbestos? Asbestos is a term applied to a group of minerals formed into rock and mined in a similar way to coal. In this form, asbestos is made up of strong, fine and flexible

More information

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours Pleura Visceral pleura covers lungs and extends into fissures Parietal pleura limits mediastinum and covers dome of diaphragm and inner aspect of chest wall. Two layers between them (pleural cavity) contains

More information

Nuevas tecnologías basadas en biomarcadores para oncología

Nuevas tecnologías basadas en biomarcadores para oncología Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS

More information

5 Frequently Asked Questions About Adult Stem Cell Research

5 Frequently Asked Questions About Adult Stem Cell Research 5 Frequently Asked Questions About Adult Stem Cell Research Stem cells are often referred to in the sociopolitical realm with some level of controversy and beyond that, some level of confusion. Many researchers

More information

Pulmonary Rehabilitation Outpatient Program

Pulmonary Rehabilitation Outpatient Program Pulmonary Rehabilitation Outpatient Program About Pulmonary Rehabilitation Pulmonary Rehabilitation is for people with chronic lung disease who are limited by breathlessness. This program may be suitable

More information

Cystic Fibrosis. Cystic fibrosis affects various systems in children and young adults, including the following:

Cystic Fibrosis. Cystic fibrosis affects various systems in children and young adults, including the following: Cystic Fibrosis What is cystic fibrosis? Cystic fibrosis (CF) is an inherited disease characterized by an abnormality in the glands that produce sweat and mucus. It is chronic, progressive, and is usually

More information

1 ALPHA-1. The Liver and Alpha-1 Antitrypsin Deficiency (Alpha-1) FOUNDATION FOUNDATION. A patient s guide to Alpha-1 liver disease

1 ALPHA-1. The Liver and Alpha-1 Antitrypsin Deficiency (Alpha-1) FOUNDATION FOUNDATION. A patient s guide to Alpha-1 liver disease The Liver and Alpha-1 Antitrypsin Deficiency (Alpha-1) 1 ALPHA-1 FOUNDATION The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of people

More information

The Liver and Alpha-1. Antitrypsin Deficiency (Alpha-1) 1 ALPHA-1 FOUNDATION

The Liver and Alpha-1. Antitrypsin Deficiency (Alpha-1) 1 ALPHA-1 FOUNDATION The Liver and Alpha-1 Antitrypsin Deficiency (Alpha-1) 1 ALPHA-1 FOUNDATION What Is Alpha-1 Antitrypsin Deficiency? Alpha-1 is a condition that may result in serious lung disease in adults and/or liver

More information

MEDICAL BREAKTHROUGHS RESEARCH SUMMARY

MEDICAL BREAKTHROUGHS RESEARCH SUMMARY MEDICAL BREAKTHROUGHS RESEARCH SUMMARY TOPIC: Training the Body to Fight Melanoma REPORT: 3823 BACKGROUND: Melanoma is the most dangerous form of skin cancer that can be hard to treat and fatal if not

More information

WA Asbestos Review Program

WA Asbestos Review Program WA Asbestos Review Program Dr Fraser Brims Consultant Respiratory Physician, SCGH, Head of Occupational and Respiratory Health Unit, LIWA Asbestos awareness week seminar, 2014 Introduction Asbestos and

More information

Summary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor)

Summary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor) EMA/662624/2015 Summary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor) This is a summary of the risk management plan (RMP) for Orkambi, which details the measures to be taken

More information

September 2008 [KT 168] Sub. Code: 2063 M.D. DEGREE EXAMINATION Branch XVII Tuberculosis and Respiratory Diseases NON-TUBERCULOSIS CHEST DISEASES Common to Part II Paper II - (Old /New/Revised Regulations)

More information

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.

More information

Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC

Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Documenting & Coding Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Sr. Provider Training & Development Consultant Professional Profile David Brigner currently performs

More information

RESEARCH PROJECTS 2015

RESEARCH PROJECTS 2015 RESEARCH PROJECTS 2015 Queen Elizabeth II Medical Centre Unit School of Medicine and Pharmacology Address: Harry Perkins Institute of Medical Research Building, QQ Block, Queen Elizabeth II Medical Centre,

More information

Project ideas of University of Udine for Horizon 2020 Health 2014/2015 www.uniud.it

Project ideas of University of Udine for Horizon 2020 Health 2014/2015 www.uniud.it Project ideas of University of Udine for Horizon 2020 Health 2014/2015 www.uniud.it The University of Udine is an Italian Public University founded in 1978 by National Law No. August 8, 1977 546, art.

More information

ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES

ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES DESCRIPTION OF GRANT MECHANISM The Alliance for Lupus Research (ALR) is an independent,

More information

Spirometry, COPD and lung cancer

Spirometry, COPD and lung cancer Spirometry, COPD and lung cancer Associate Professor Robert Young BMedSc, MBChB, DPhil (Oxon), FRACP, FRCP University of Auckland, New Zealand Spirometry for those with smoking and dust exposures Risk

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Surgeons Role in Symptom Management A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Conditions PLEURAL Pleural effusion Pneumothorax ENDOBRONCHIAL Haemoptysis

More information

ITT Advanced Medical Technologies (Ileri Tip Teknolojileri)

ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,

More information

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance A. Bernheim Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MyR is funded by the European Commission within its FP7 specific

More information

Asbestos Related Diseases

Asbestos Related Diseases Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease Asbestosis and Mesothelioma (LUNG CANCER) Support Group 1800 017 758 www.amsg.com.au ii Helping you and your family through

More information

Asbestos Related Diseases. Asbestosis Mesothelioma Lung Cancer Pleural Disease. connecting raising awareness supporting advocating

Asbestos Related Diseases. Asbestosis Mesothelioma Lung Cancer Pleural Disease. connecting raising awareness supporting advocating Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease connecting raising awareness supporting advocating 1800 017 758 www.asbestosassociation.com.au Asbestos lagging was widely

More information

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:

More information

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery Section 2 Overview of Obesity, Weight Loss, and Bariatric Surgery What is Weight Loss? How does surgery help with weight loss? Short term versus long term weight loss? Conditions Improved with Weight Loss

More information

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions

More information

Recurrent or Persistent Pneumonia

Recurrent or Persistent Pneumonia Recurrent or Persistent Pneumonia Lower Respiratory Tract Dr T Avenant Recurrent or Persistent Pneumonia Definitions Recurrent pneumonia more than two episodes of pneumonia in 18 months Persistent pneumonia

More information

Human Health Sciences

Human Health Sciences Human Health Sciences WITH PLYMOUTH UNIVERSITY DISCOVER MORE If you would like to visit Plymouth and meet our staff, then why not come along to one of our open days. Human Health Sciences WITH PLYMOUTH

More information

is working on is about nutrition, specifically as it pertains to Alpha- continued on page 2

is working on is about nutrition, specifically as it pertains to Alpha- continued on page 2 Alpha-1 Canada Update May 2010 It has been very busy here over the last few months. Well it always seems to be busy, but lately exceptionally so. As this newsletter goes to press we are only days away

More information

Asbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer

Asbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer Asbestos Health Risks Dr Andrew Pengilley Acting Chief Health Officer Asbestos Asbestos is a name given to several different fibrous minerals Three main commercial types are Chrysotile (white asbestos)

More information

Kentucky Lung Cancer Research Program. 2010 Strategic Plan Update

Kentucky Lung Cancer Research Program. 2010 Strategic Plan Update Kentucky Lung Cancer Research Program 2010 Strategic Plan Update Approved by the KLCR Program Governance Board August 12, 2009 KLCR Program Strategic Plan Table of Contents Introduction... 3 GOAL 1: Investigator-Initiated

More information

Pleural Disease Chapter 14

Pleural Disease Chapter 14 14 Pleural Disease The pleura is a thin tissue covered by a layer of cells (mesothelial cells) that surrounds the lungs and lines the inside of the chest wall. The pleural space is the area between the

More information

A leader in the development and application of information technology to prevent and treat disease.

A leader in the development and application of information technology to prevent and treat disease. A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today

More information

Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease

Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease 80 Liver Disease and Obesity Liver disease biomarkers: Percent of adult population (United States)

More information

2009 annual report. 10th Anniversary Edition

2009 annual report. 10th Anniversary Edition 2009 annual report 10th Anniversary Edition organisation chart key achievements Board Mr Bill Manning Chairman Director Winthrop Professor Philip Thompson Executive Officer Ms Tineke Van der Eecken Celebration

More information

Pathologist s Discussion of Plaintiffs Latest Theories

Pathologist s Discussion of Plaintiffs Latest Theories Pathologist s Discussion of Plaintiffs Latest Theories Mary Beth Beasley, MD Mt. Sinai Medical Center Annenberg Building 15th Floor Room 50 1468 Madison Avenue New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com

More information

DIAPHRAGM. DIAgnostic and Prognostic biomarkers in the Rational Assessment of Mesothelioma

DIAPHRAGM. DIAgnostic and Prognostic biomarkers in the Rational Assessment of Mesothelioma DIAPHRAGM DIAgnostic and Prognostic biomarkers in the Rational Assessment of Mesothelioma Kevin Blyth Consultant Respiratory Physician, Southern General Hospital NRS Research Fellow & Honorary Clinical

More information

X-Plain Pneumonia Reference Summary

X-Plain Pneumonia Reference Summary X-Plain Pneumonia Reference Summary Introduction Pneumonia is an inflammation and infection of the lungs. Every year, more than 60,000 Americans die of pneumonia. It can affect anybody, but is more dangerous

More information

Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis What is Idiopathic Pulmonary Fibrosis? Idiopathic pulmonary fibrosis (IPF) is a condition that causes persistent and progressive scarring of the tiny air sacs (alveoli) in

More information

Emphysema and COPD. What is emphysema? What is obstruction of the small airways?

Emphysema and COPD. What is emphysema? What is obstruction of the small airways? Emphysema and COPD Chronic obstructive pulmonary disease (COPD) is a serious long-term lung condition that limits airflow causing shortness of breath. 1 It worsens over time and is largely not reversible.

More information

Population Health Management Program

Population Health Management Program Population Health Management Program Program (formerly Disease Management) is dedicated to improving our members health and quality of life. Our Population Health Management Programs aim to improve care

More information

FACULTY OF MEDICAL SCIENCE

FACULTY OF MEDICAL SCIENCE Doctor of Philosophy Program in Microbiology FACULTY OF MEDICAL SCIENCE Naresuan University 171 Doctor of Philosophy Program in Microbiology The time is critical now for graduate education and research

More information

Science Highlights. To PSA or not to PSA: That is the Question.

Science Highlights. To PSA or not to PSA: That is the Question. Science Highlights June 2012 by Ann A. Kiessling, PhD at the To PSA or not to PSA: That is the Question. The current raucous debate over the commonly used PSA blood test to screen for prostate cancer,

More information

If you were diagnosed with cancer today, what would your chances of survival be?

If you were diagnosed with cancer today, what would your chances of survival be? Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However

More information

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of

More information

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003 ASBESTOS Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003 Asbestosis Asbestosis is a model for other dust diseases as well as

More information

Oxygen - update April 2009 OXG

Oxygen - update April 2009 OXG PRESENTATION Oxygen (O 2 ) is a gas provided in compressed form in a cylinder. It is also available in liquid form, in a system adapted for ambulance use. It is fed via a regulator and flow meter to the

More information

Summary of the risk management plan (RMP) for Ofev (nintedanib)

Summary of the risk management plan (RMP) for Ofev (nintedanib) EMA/738120/2014 Summary of the risk management plan (RMP) for Ofev (nintedanib) This is a summary of the risk management plan (RMP) for Ofev, which details the measures to be taken in order to ensure that

More information

2019 Healthcare That Works for All

2019 Healthcare That Works for All 2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To

More information

Milano, 9-12 Luglio 2012 Hotel Enterprise

Milano, 9-12 Luglio 2012 Hotel Enterprise Milano, 9-12 Luglio 2012 Hotel Enterprise Organized by: Endorsed by: BACKGROUND The HERMES National Summer School is an educational project organized by SIMeR and established with the goal to develop standards

More information

Transcript for Asbestos Information for the Community

Transcript for Asbestos Information for the Community Welcome to the lecture on asbestos and its health effects for the community. My name is Dr. Vik Kapil and I come to you from the Centers for Disease Control and Prevention, Agency for Toxic Substances

More information

F r e q u e n t l y As k e d Qu e s t i o n s. Lung Disease

F r e q u e n t l y As k e d Qu e s t i o n s. Lung Disease Lung Disease page 1 Q: What is lung disease? A: Lung disease refers to disorders that affect the lungs, the organs that allow us to breathe. Breathing problems caused by lung disease may prevent the body

More information

Pulmonary Diseases. Lung Disease: Pathophysiology, Medical and Exercise Programming. Overview of Pathophysiology

Pulmonary Diseases. Lung Disease: Pathophysiology, Medical and Exercise Programming. Overview of Pathophysiology Lung Disease: Pathophysiology, Medical and Exercise Programming Overview of Pathophysiology Ventilatory Impairments Increased airway resistance Reduced compliance Increased work of breathing Ventilatory

More information

A Genetic Analysis of Rheumatoid Arthritis

A Genetic Analysis of Rheumatoid Arthritis A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.

More information

10/31/2014. Much is unknown. What is npod? THE JDRF Network for the Pancreatic Organ Donor with Diabetes (npod):

10/31/2014. Much is unknown. What is npod? THE JDRF Network for the Pancreatic Organ Donor with Diabetes (npod): THE JDRF Network for the Pancreatic Organ Donor with Diabetes (npod): a biobank and a collaborative project about the pathogenesis of type 1 diabetes Alberto Pugliese, MD 23 rd ADA Annual Conference on

More information

Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW

Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW Lung disease in Australia Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW Prepared for Lung Foundation Australia

More information

Animal Pharming: The Industrialization of Transgenic Animals December 1999

Animal Pharming: The Industrialization of Transgenic Animals December 1999 Animal Pharming: The Industrialization of Transgenic Animals December 1999 Animal pharming, the process of using transgenic animals to produce human drugs, is staking its claim in a lucrative world market.

More information

Recruiting now. Could you help by joining this study?

Recruiting now. Could you help by joining this study? Non-Small Cell Lung Cancer Recruiting now AstraZeneca is looking for men and women with locally advanced or metastatic non-small cell lung cancer (NSCLC) to join ATLANTIC, a clinical study to help investigate

More information

Key Facts about Influenza (Flu) & Flu Vaccine

Key Facts about Influenza (Flu) & Flu Vaccine Key Facts about Influenza (Flu) & Flu Vaccine mouths or noses of people who are nearby. Less often, a person might also get flu by touching a surface or object that has flu virus on it and then touching

More information

Asbestos risks, safety and its role in lung disease

Asbestos risks, safety and its role in lung disease Asbestos risks, safety and its role in lung disease Fraser Brims Respiratory Physician, SCGH Head of Occupa9onal and Respiratory Health Unit, Ins9tute for Lung Health, WA Lung Founda9on Australia Educa9on

More information

Idiopathic Pulmonary Fibrosis (IPF) Research

Idiopathic Pulmonary Fibrosis (IPF) Research Idiopathic Pulmonary Fibrosis (IPF): Why Early Referral is Critical Even if Your Patient is Not Eligible for a Clinical Trial Idiopathic Pulmonary Fibrosis (IPF) Research Management of IPF requires a confident

More information

Oxygen Therapy. Oxygen therapy quick guide V3 July 2012.

Oxygen Therapy. Oxygen therapy quick guide V3 July 2012. PRESENTATION Oxygen (O 2 ) is a gas provided in a compressed form in a cylinder. It is also available in a liquid form. It is fed via a regulator and flow meter to the patient by means of plastic tubing

More information

BIOBANKING a challenge for public / private partnerships. Christian Bréchot

BIOBANKING a challenge for public / private partnerships. Christian Bréchot BIOBANKING a challenge for public / private partnerships Christian Bréchot Patient Disease Diagnosis Targeted Personalized therapies Risk medecine prediction Biomarker Diagnostic Theranostic: Efficay Toxicity

More information

ICD 10 High Overview

ICD 10 High Overview ICD 10 High Overview 1 FAQs: ICD-10 Transition Basics 1. What is the ICD-10 compliance date? October 1, 2014. 2. Will the transition to ICD-10 be postponed? No. The October 1, 2014 compliance date is firm.

More information

University of Illinois Medical Center Chicago, Illinois M.S. (Masters of Health Professions Education) June 1979

University of Illinois Medical Center Chicago, Illinois M.S. (Masters of Health Professions Education) June 1979 Education: Attended: Graduate: University of South Alabama College of Medicine Department of Physiology Ph.D. Candidate Mobile, Alabama 1990-1991 University of Illinois Medical Center Chicago, Illinois

More information

Circular Instructions related to occupational lung diseases

Circular Instructions related to occupational lung diseases Circular Instructions related to occupational lung diseases Compensation Fund Dr Monge Lekalakala OCCUPATIONAL DISEASES According to Section 65(1) of the COID ACT: a) An Occupational disease disease arising

More information

BSc in Medical Sciences with PHARMACOLOGY

BSc in Medical Sciences with PHARMACOLOGY BSc in Medical Sciences with PHARMACOLOGY Course Director Dr Christopher John Module Leaders Dr Robert Dickinson (Module 1) Dr Anabel Varela Carver (Module 2) Dr Sohag Saleh (Module 3) Course Administrator

More information

RICERCA FINALIZZATA+GIOVANI RICERCATORI MALATTIE RARE. Graduatoria e Finanziamento

RICERCA FINALIZZATA+GIOVANI RICERCATORI MALATTIE RARE. Graduatoria e Finanziamento Direzione Generale Ricerca Scientifica e Tecnologica RICERCA FINALIZZATA+GIOVANI RICERCATORI MALATTIE RARE Graduatoria e Finanziamento Ministero della Salute Direzione Generale Ricerca Scientifica e Tecnologica

More information

If you are signing for a minor child, you refers to your child throughout the consent document.

If you are signing for a minor child, you refers to your child throughout the consent document. CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY Adult Patient or Parent, for Minor Patient INSTITUTE: National Cancer Institute PRINCIPAL INVESTIGATOR: Raffit Hassan, M.D. STUDY TITLE: Tissue Procurement

More information

Future Oncology: Technology, Products, Market and Service Opportunities

Future Oncology: Technology, Products, Market and Service Opportunities Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter

More information

Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare

Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare Paula Corabian, Dagmara Chojecki March 6, 2012 Objectives Provincial Health Technology Assessment (HTA) Program

More information

Overview of the Cattle Immune System 1

Overview of the Cattle Immune System 1 Oregon State University BEEF043 Beef Cattle Library Beef Cattle Sciences Overview of the Cattle Immune System 1 Reinaldo F. Cooke 2 Introduction On average, the U.S. cattle industry loses more than $1

More information

Cystic Fibrosis. - incidence: 1 in 2000-3000; predominantly Caucausian populations (carrier frequency 1 in 22-28)

Cystic Fibrosis. - incidence: 1 in 2000-3000; predominantly Caucausian populations (carrier frequency 1 in 22-28) Cystic Fibrosis - lethal autosomal recessive disease - incidence: 1 in 2000-3000; predominantly Caucausian populations (carrier frequency 1 in 22-28) - disease gene CFTR (cystic fibrosis transmembrane

More information

NURSING CARE PLANS. mjmanalangquintornusrn

NURSING CARE PLANS. mjmanalangquintornusrn NURSING CARE PLANS Nursing Care Plan Known to be the blueprint of the nursing process Used to identify the scope and depth of the nursing practice Evidenced by: Sufficient data collection At least one

More information